ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0998689 | The only and type species of Hemicentrotus. | Hemicentrotus pulcherrimus | Hemicentrotus pulcherrimus |
C1289048 | null | Entire left sphenoid sinus|Entire left sphenoid sinus (body structure) | Entire left sphenoid sinus |
C0925580 | null | Apertura piriformis|Piriform aperture | Piriform aperture |
C0021289 | An infant during the first 28 days after birth. | NEONATE|neonate|Newborn infants|newborn human (0-6 weeks)|neonates|Newborn Infants|Neonatal|0-6 weeks old|newborn infants|infant newborn|Neonate|Newborn (person)|Newborns|newborn infant|NEWBORN|newborns|Infant, Newborn|Infants, Newborn|Infants (Newborn)|Newborn|newborn|newborn baby|Newborn Infant|Neonates | Infant, Newborn |
C1519221 | One of several types of cells that generate and secrete a substance to be used by the organism. | Secretory Cell | Secretory cell |
C0118132 | null | null | formiminotransferase-cyclodeaminase |
C0007708 | Self-replicating, short, fibrous, rod-shaped organelles. Each centriole is a short cylinder containing nine pairs of peripheral microtubules, arranged so as to form the wall of the cylinder. | Centriole, NOS|centrioles|Centriole structure (cell structure)|Centriole (cell)|Centriole|Centrioles|centriole|Centriole structure | Centrioles |
C0054036 | A fungal metabolite which is a macrocyclic lactone exhibiting a wide range of antibiotic activity. | decumbin|Ascotoxin|ascotoxin|Cyanein|brefeldin A|cyanein|Decumbin|4H-Cyclopent(f)oxacyclotridecin-4-one,1,6,7,8,9,11a-beta,12,13,14,14a-alpha-decahydro-1-beta-13-alpha-dihydroxy-6-beta-methyl-|Synergisidin | Brefeldin A |
C0813866 | null | colcemid|Colcemid | Colcemide |
C0242608 | The cell center, consisting of a pair of CENTRIOLES surrounded by a cloud of amorphous material called the pericentriolar region. During interphase, the centrosome nucleates microtubule outgrowth. The centrosome duplicates and, during mitosis, separates to form the two poles of the mitotic spindle (MITOTIC SPINDLE APPARATUS). | Centrosome|Centrosomes|Centrosome (cell structure)|centrosome | Centrosome |
C0009380 | Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing. | Count, Microbial Colony|Colony Forming Units Assay, Microbial|Microbial Colony Counts|Counts, Microbial Colony|Colony Forming Units Assays, Microbial|Microbial Colony Count|Colony-Forming Units Assay, Microbial|Colony Counts, Microbial | Colony Count, Microbial |
C0009380 | Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing. | Count, Microbial Colony|Colony Forming Units Assay, Microbial|Microbial Colony Counts|Counts, Microbial Colony|Colony Forming Units Assays, Microbial|Microbial Colony Count|Colony-Forming Units Assay, Microbial|Colony Counts, Microbial | Colony Count, Microbial |
C0751615 | null | intracranial arachnoid cyst|Cyst, Intracranial Arachnoid|Arachnoid Cysts, Intracranial|intracranial arachnoid cysts|Cysts, Intracranial Arachnoid|Arachnoid Cyst, Intracranial|Intracranial Arachnoid Cyst|arachnoid intracranial cyst|ARACHNOID CYSTS, INTRACRANIAL | Intracranial Arachnoid Cysts |
C1273870 | The act of conducting, controlling or supervising something. | Supervision|Management procedure|Management procedure (procedure)|management procedure|management procedures|Management|Oversight|Managed|Managing | Management procedure |
C0042449 | The vessels carrying blood away from the CAPILLARY BEDS. | Venae|Vein, NOS|VEINS|Venous tree (organ part)|Venous structure|veins|Venous tree|Veins|Venous vessel|vein|veined|Venous subtree|Vein|Venous|Venous structure (body structure)|VEIN|Veins set|Set of veins|Venous tree organ part|Set of systemic veins | Veins |
C0442893 | Disease that affects the whole body. | Systemic illness|Systemic disease (disorder)|Systemic disease, NOS|Systemic disease|diseases systemic|Systemic Disease|disease systemic|Systemic Disorder|illnesses systemic|Systemic illness (qualifier value)|systemic disease|systemic illness | Systemic disease |
C0042018 | Low-density crystals or stones in any part of the URINARY TRACT. Their chemical compositions often include CALCIUM OXALATE, magnesium ammonium phosphate (struvite), CYSTINE, or URIC ACID. | uroliths|CALCULUS URINARY (NOS)|URINARY CALCULUS|urinary stones|Stones, Urinary|calculi urinary|stones urinary|Urinary calculus|Stone, Urinary|stones urinary tract|urinary stone|Stone, Urinary Tract|urinary tract stone|Urolith (finding)|Urinary Calculi|Urinary Stones|Urinary stone|stones tract urinary|Urolith, NOS|Urolith|Calculus of urinary tract|urinary calculi|URINARY TRACT STONE|stone urinary|Urinary Tract Stones|urinary calculus|Calculi, Urinary|Calculus, Urinary|Urinary Stone|urolith|Urinary Tract Stone|Urinary Calculus|urinary tract stones|Stones, Urinary Tract | Urinary Calculi |
C0023869 | A condition characterized by the formation of CALCULI and concretions in the hollow organs or ducts of the body. They occur most often in the gallbladder, kidney, and lower urinary tract. | Calculoses|Calculosis, NOS|Lithiasis|Calculosis|Lithiases|calculosis|Lithiasis (morphologic abnormality)|Lithiasis, NOS|lithiasis | Lithiasis |
C0026141 | null | MILK DRINKER SYNDROME|Burnett's syndrome|burnett syndrome|drinkers milk syndrome|burnett's syndrome|Milk alkali syndrome (disorder)|milk alkali syndrome|Milk-alkali syndrome|MILK-ALKALI SYNDROME|BURNETT SYNDROME|Milk alkali syndrome|Milk Alkali Syndrome|milk-alkali syndrome|Syndrome, Milk-Alkali | Milk-Alkali Syndrome |
C0029163 | Bleeding from the blood vessels of the mouth, which may occur as a result of injuries to the mouth, accidents in oral surgery, or diseases of the gums. | mouth bleeding|Haemorrhage from mouth|Oral haemorrhage|Bleeding from mouth|MOUTH BLEEDING|oral bleeding|Hemorrhage, Oral|ORAL HAEMORRHAGE|Oral hemorrhage|MOUTH HEMORRHAGE|ORAL HEMORRHAGE|Stomatorrhagia|Bleeding from mouth (finding)|Oral bleeding|HEMORRHAGE ORAL|oral hemorrhage|Hemorrhage from mouth|HEMORRHAGE MOUTH|bleeding mouth|bleeding from mouth|bleeding in mouth|haemorrhage oral|ORAL BLEEDING|Oral Hemorrhages|Bleeding of mouth|Bleeding in mouth|Oral Hemorrhage | Oral Hemorrhage |
C0149523 | An acute infection of the bladder. It is usually caused by bacteria. Signs and symptoms include increased frequency of urination, pain or burning during urination, fever, cloudy or bloody urine, and suprapubic pain. | Acute cystitis (disorder)|Acute cystitis|Acute Cystitis|acute cystitis|CYSTITIS, ACUTE|cystitis acute | Acute cystitis |
C0520575 | Sudden onset pyelonephritis. | PYELONEPHRITIS ACUTE|Acute kidney infection|Acute pyelonephritis (disorder)|Acute pyelonephritis|Acute Pyelonephritis|Acute PN - pyelonephritis|PYELONEPHRITIS, ACUTE|APN - Acute pyelonephritis|acute pyelonephritis | Acute pyelonephritis |
C0282488 | A condition with recurring discomfort or pain in the URINARY BLADDER and the surrounding pelvic region without an identifiable disease. Severity of pain in interstitial cystitis varies greatly and often is accompanied by increased urination frequency and urgency. | Interstitial Cystitides|Ulcerative cystitis (disorder)|interstitial cystitis|Interstitial cystitis|Cystitis, Interstitial|CYSTITIS ULCERATIVE|Interstitial Cystitis|Cystitides, Interstitial|IC|INTERSTITIAL CYSTITIS|painful bladder syndrome (PBS)|Ulcerative cystitis|IC - Interstitial cystitis|interstitial cystitis (IC)|CYSTITIS INTERSTITIAL | Interstitial Cystitis |
C0080039 | A strong ligament of the knee that originates from the anterolateral surface of the medial condyle of the femur, passes posteriorly and inferiorly between the condyles, and attaches to the posterior intercondylar area of the tibia. | Cruciate Ligament, Posterior|Posterior Cruciate Ligaments|Posterior cruciate ligament|Posterior cruciate ligament of knee joint|Structure of posterior cruciate ligament of knee joint (body structure)|Cruciate Ligaments, Posterior|Posterior Cruciate Ligament|Structure of posterior cruciate ligament of knee joint|posterior cruciate ligament|Ligamentum cruciatum posterius|cruciate ligament posterior|Ligaments, Posterior Cruciate|Ligament, Posterior Cruciate | Posterior Cruciate Ligament |
C0009068 | null | Closure by suture|closures suture|Closure by suture, NOS (-rhaphy)|Closure by suture, NOS|Suturing|suturing|closure suture|Closure by suture (procedure)|closure sutures|sutur|Suture, NOS|suture closure | Closure by suture |
C0524724 | null | Staple, Surgical|Surgical staple (physical object)|staples surgical|staples|Staple, device (physical object)|Staple|staple|Staple, NOS|Surgical Staples|Staple, device|Surgical Staple|Surgical staple|surgical staples|Staples, Surgical|surgical staple | Staple, Surgical |
C0849355 | Taken out of, separated from, or eliminated. | removes|Eliminated|Taken Out|Removed|remove|Out | Removed |
C1278953 | null | Entire popliteal artery (body structure)|Entire popliteal artery | Entire popliteal artery |
C0185373 | Restoration of normal alignment of a fractured bone via an OPERATIVE SURGICAL PROCEDURE. | Open Fracture Reduction|open reduction|Open # reduction|Open reduction of fracture|Open reduction of fracture, NOS|Open reduction of fracture (procedure)|Open Reductions, Fracture|Fracture Open Reductions|fracture open reduction|Open Reduction, Fracture|Reductions, Fracture Open|Reduction, Fracture Open|open reduction of fracture|Fracture Open Reduction|Fracture Reduction, Open|Open Fracture Reductions | Open reduction of fracture |
C1279571 | null | Entire right knee|Entire right knee (body structure) | Entire right knee |
C0072108 | Nuclear antigen with a role in DNA synthesis, DNA repair, and cell cycle progression. PCNA is required for the coordinated synthesis of both leading and lagging strands at the replication fork during DNA replication. PCNA expression correlates with the proliferation activity of several malignant and non-malignant cell types. | Proliferating Cell Nuclear Antigen|DNA Polymerase Delta Auxiliary Protein|Cyclin|proliferating cell nuclear antigen (PCNA)|PCNA|pcna|proliferating cell nuclear antigen|Antigen, Proliferating Cell Nuclear | Proliferating Cell Nuclear Antigen |
C1177422 | null | benzocaine 20 % / triclosan 0.13 % Topical Spray|BENZOCAINE 200 mg in 1 mL / TRICLOSAN 1.3 mg in 1 mL TOPICAL SPRAY [First Degree Burn]|BENZOCAINE 20 g in 100 g / TRICLOSAN 130 mg in 100 g TOPICAL AEROSOL, SPRAY [Good Neighbor Pharmacy First Aid]|BENZOCAINE 17 g in 85 g / TRICLOSAN 0.11 g in 85 g TOPICAL AEROSOL, SPRAY [Benzocaine and Triclosan] | Benzocaine 200 MG/ML / Triclosan 1.3 MG/ML Topical Spray |
C1177422 | null | benzocaine 20 % / triclosan 0.13 % Topical Spray|BENZOCAINE 200 mg in 1 mL / TRICLOSAN 1.3 mg in 1 mL TOPICAL SPRAY [First Degree Burn]|BENZOCAINE 20 g in 100 g / TRICLOSAN 130 mg in 100 g TOPICAL AEROSOL, SPRAY [Good Neighbor Pharmacy First Aid]|BENZOCAINE 17 g in 85 g / TRICLOSAN 0.11 g in 85 g TOPICAL AEROSOL, SPRAY [Benzocaine and Triclosan] | Benzocaine 200 MG/ML / Triclosan 1.3 MG/ML Topical Spray |
C1335175 | A serous cystadenoma of the ovary characterized by the presence of small papillary projections in the inner surface of the cysts. | null | Ovarian Papillary Cystadenoma |
C1335175 | A serous cystadenoma of the ovary characterized by the presence of small papillary projections in the inner surface of the cysts. | null | Ovarian Papillary Cystadenoma |
C1513899 | Component of the NATIONAL INSTITUTES OF HEALTH. It supports a comprehensive research portfolio that focuses on the biological, social, behavioral and neuroscientific bases of drug abuse on the body and brain as well as its causes, prevention, and treatment. NIDA, NIAAA, and NIMH were created as coequal institutes within the Alcohol, Drug Abuse and Mental Health Administration in 1974. It was established within the NATIONAL INSTITUTES OF HEALTH in 1992. | National Institute on Drug Abuse|NIDA|National Institute of Drug Abuse|National Institute on Drug Abuse (U.S.)|NIDA (US) | National Institute of Drug Abuse |
C0233397 | null | psychological symptoms|Psychological symptom (finding)|Psychological symptom, NOS|psychological symptom | Psychological symptom |
C1519386 | An indication of a person's current tobacco and nicotine consumption as well as some indication of smoking history. | Current Tobacco and Nicotine Consumption Status|Smoking Status | Smoking Status |
C0015732 | Failure of voluntary control of the anal sphincters, with involuntary passage of feces and flatus. | fecal incontinence|FECES INCONTINENCE OF|Incontinence, Bowel|Loss of bowel control|Bowel incontinence|incontinence faecal|Anal incontinence|Incontinence of feces|Fecal incontinence NOS|of bowel incontinence|Bowels: incontinent|Incontinence of feces (finding)|Fecal Incontinence|INCONTINENCE FECAL|incontinent of stool|Incontinence of faeces|incontinence bowel|FAECAL INCONTINENCE|Bowel Incontinence|bowel incontinent|Stool soiling|stool incontinence|incontinent bowel|Involuntary stool|incontinence of stool|BOWEL INCONTINENA|Feces Incontinence|Incontinent of feces|Incontinent of faeces|bowel incontinence|Faecal incontinence|Alteration in bowel elimination: incontinence|Fecal incontinence|Incontinence, Fecal|faecal incontinence|FECAL INCONTINENCE|incontinence stool | Fecal Incontinence |
C1305040 | null | null | Entire external anal sphincter |
C0587437 | A medical facility which provides a high degree of subspecialty expertise for patients from centers where they received SECONDARY CARE. | Tertiary referral hospital|Tertiary referral hospital (environment)|Hospitals, Tertiary|Hospital, Tertiary Referral|Tertiary referral centre|Centers, Tertiary Referral|Care Centers, Tertiary|Tertiary Referral Centers|care centers tertiary|Referral Centers, Tertiary|Referral Hospitals, Tertiary|Tertiary Referral Center|Hospital, Tertiary|Center, Tertiary Referral|Referral Center, Tertiary|Tertiary Hospitals|Referral Hospital, Tertiary|TERTIARY CARE CENTER|Tertiary care center|Tertiary Referral Hospital|Care Center, Tertiary|Centers, Tertiary Care|Tertiary Referral Hospitals|Hospitals, Tertiary Referral|Tertiary care centre|tertiary care center|Tertiary referral center|Tertiary Care Center|Tertiary Hospital|Center, Tertiary Care | Tertiary Care Centers |
C0009378 | Endoscopic examination, therapy or surgery of the luminal surface of the colon. | Endoscopic examination of colon|Colonoscopies|colon endoscopy|Lower gastrointestinal tract examination|colonoscopy procedures|colonoscopies|Endoscopy of colon, NOS|Endoscopy of colon|colonoscopy procedure|colonoscopic studies|Colonoscopy|colonoscopy|Colonoscopy, NOS|Colonoscopy (procedure) | colonoscopy |
C0011991 | An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. | Diarrhea, NOS|Diarrhea NOS|Diarrhoea symptom|watery stool|STOOLS LOOSE|diarrheas|diarrhoea|bowel loose movements|bowels loose movement|Loose Stools|loose bowel movement|Frequent Stools|Diarrhoea|Diarrhea symptom|Diarrhea symptom (finding)|symptoms diarrhea|Watery stool|diarrhea symptoms|loose bowel motion|Diarrhea|diarrhea running|watery stools|DIARRHEA|LOOSE STOOLS|Diarrheas|The trots|diarrhea|D - Diarrhoea|Observation of diarrhea|Loose stools|diarrhoea symptoms|D - Diarrhea|DIARRHOEA|The runs|Diarrheal Disease|Observation of diarrhoea|Diarrhea (finding) | Diarrhea |
C0009319 | Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER. | COLITIS (NOS)|colon (non-specific) inflammation|Colitis, NOS|Colon inflammation|COLITIS|colon inflammation|Inflammation of colon|Colitides|Colitis (disorder)|Colon inflamed|Colitis|colitis | Colitis |
C0401151 | The presence of chronic diarrhea, which is usually taken to mean diarrhea that has persisted for over 4 weeks. [HPO:probinson] | Diarrhea Chronic|Chronic diarrhoea|Recurrent diarrhea|Chronic diarrhea|DIARRHEA, CHRONIC|diarrhea chronic|chronic diarrhoea|Chronic diarrhea (disorder)|Diarrhea, recurrent|chronic diarrhea|Diarrhea, chronic | Chronic diarrhea |
C0005978 | Steel wires, often threaded through the skin, soft tissues, and bone, used to fix broken bones. Kirschner wires or apparatus also includes the application of traction to the healing bones through the wires. | surgical wires|bone wire|Bone wire|Wire, Bone|Bone wire, device|Bone wire, device (physical object)|Wires, Bone|WIRE, SURGICAL|Wire|Bone Wire|Bone Wires|Wires | Bone Wires |
C0020885 | The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE. | Ileal structure (body structure)|Ileum|ileos|ILEUM|Ileal structure|Ileal|ileum|Ileum, NOS|SMALL INTESTINE, ILEUM|Ileo-|ileo|ileal | ileum |
C0015684 | Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) | Acids, Fatty|Fatty Acid|Fatty acids|fatty acids|FATTY ACID|Fatty Acids|Fatty acid, NOS|Fatty acid|Fatty acid (substance)|fatty acid | Fatty Acids |
C0016157 | Oils high in unsaturated fats extracted from the bodies of fish or fish parts, especially the LIVER. Those from the liver are usually high in VITAMIN A. The oils are used as DIETARY SUPPLEMENTS. They are also used in soaps and detergents and as protective coatings. | Fish oils|Seafood Oil|fish oils|Fish Oil|Fish oil|Oils, Fish|fish oil|Fish derived omega 3 fatty acid-containing product|Product containing fish derived omega 3 fatty acid (medicinal product)|Omega-3 fish oil|fish oil products|Fish oil containing omega-3 acids|FISH OIL|oil, fish|seafood oil|Oil, Fish|Fish oil (substance)|Fish Oils | fish oils |
C0038179 | Any of a group of polysaccharides of the general formula (C6-H10-O5)n, composed of a long-chain polymer of glucose in the form of amylose and amylopectin. It is the chief storage form of energy reserve (carbohydrates) in plants. | Starch (substance)|Starch-containing product|Product containing starch (medicinal product)|Starch, NOS|Starch|starches|starch|STARCH | starch |
C0399713 | null | Proximal gastrectomy|Proximal subtotal gastrectomy|Proximal subtotal gastrectomy (procedure) | Proximal subtotal gastrectomy |
C0006153 | Any tests done on exhaled air. | breath test|Tests, Breath|Breath test (procedure)|breath analysis|Breath tests|breath tester|Breath Test|Test, Breath|breathing tests|breath tests|breathing test|Breath test | Breath Tests |
C0267167 | null | FUNCTIONAL DYSPEPSIA|nonulcer dyspepsia|NUD (nonulcer dyspepsia)|Nonulcer dyspepsia (disorder)|Non ulcer dyspepsia|Functional dyspepsia|non-ulcer dyspepsia|gastric irritation|functional dyspepsia|dyspepsia functional|Non-ulcer dyspepsia|non ulcer dyspepsia|Nonulcer dyspepsia | Nonulcer dyspepsia |
C0019588 | An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. | HISTAMINE|histamine|beta-aminoethylglyoxaline|Histamine-containing product|Product containing histamine (medicinal product)|Histamine (substance)|2-(4-imidazolyl)ethylamine|5-Imidazoleethylamine|4-(2-Aminoethyl)-1H-imidazole|5-imidazoleethylamine|2-(4-Imidazolyl)ethylamine|Histamine|histamines|1H-Imidazole-4-ethanamine|beta-aminoethylimidazole|4-imidazoleethylamine | histamine |
C0232552 | The regulated release of gastric acid (hydrochloric acid) by parietal or oxyntic cells during digestion. [GOC:hjd] | hydrochloric acid secretion|GAS - Gastric acid secretion|Gastric acid secretion|gastric acid secretion|Gastric acid secretion, NOS|Gastric acid secretion (observable entity)|Gastric acid output|acid gastric secretion | Gastric acid secretion |
C0047039 | null | 3,5-DIABS | 3,5-diiodo-4-azidobenzenesulfonate |
C0047039 | null | 3,5-DIABS | 3,5-diiodo-4-azidobenzenesulfonate |
C0241950 | null | Bowel infarction|infarcts intestinal|intestinal infarction|Intestinal infarction|INTESTINAL INFARCTION | bowel infarction |
C0241950 | null | Bowel infarction|infarcts intestinal|intestinal infarction|Intestinal infarction|INTESTINAL INFARCTION | bowel infarction |
C1325893 | The regulated release of histamine by a cell or tissue. It is formed by decarboxylation of histidine and it acts through receptors in smooth muscle and in secretory systems. [GOC:mah, ISBN:0198506732, ISBN:0781735149] | null | histamine secretion |
C0253468 | A protein tyrosine kinase inhibitor that selectively inhibits EGFR kinase, involved in signaling pathways. (NCI) | Tyrphostin A46 | tyrphostin A46 |
C0600438 | A family of synthetic protein tyrosine kinase inhibitors. They selectively inhibit receptor autophosphorylation and are used to study receptor function. | tyrphostins|tyrphostin | Tyrphostins |
C0034665 | A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. | Ranitidin|Ranitidine|ranitidine|RANITIDINE|N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine|Product containing ranitidine (medicinal product)|Ranitidina|Ranitidine-containing product|Ranitidine (substance)|N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine|1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-|Ranitidinum|ranitidin | ranitidine |
C0017152 | Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. | Gastric inflammation|Stomach inflamed|GASTRIC INFLAMMATION|INFLAMMATION STOMACH|Gastritis, NOS|gastric inflammation|STOMACH INFLAMMATION|Gastritides|stomach inflammation|Catarrhal gastritis|Gastritis|GASTRITIS|Stomach inflammation|gastritis|Gastritis (disorder)|Gastric catarrh | Gastritis |
C0679408 | null | stomach lesion|lesions stomach|Lesion of stomach (finding)|gastric lesion | Lesion of stomach |
C0521421 | null | Aural|Entire ear|EARS|Ear, NOS|Entire vestibulocochlear organ|Entire ear (body structure) | Entire ear |
C0232483 | An abnormal backward flow of a body fluid. | reflux|refluxs|refluxing|Reflux|refluxed|Reflux, NOS | Reflux |
C0079304 | An endoscopic procedure that visualizes the upper part of the gastrointestinal tract up to the duodenum. | Fiberoptic esophagogastroduodenoscopy|EGD - Esophagogastroduodenoscopy|esophagogastroduodenoscopy|upper gastrointestinal endoscopy|endoscopy upper gi|Esophagogastroduodenoscopy|upper digestive system endoscopy|EGD - Oesophagogastroduodenoscopy|EGD|upper gi endoscopy|Fibreoptic oesophagogastroduodenoscopy|Esophagogastroduodenoscopy (procedure)|Esophagogastroduodenoscopies|endoscopy gi upper|oesophagogastroduodenoscopy|Upper gastrointestinal endoscopy|egd|Oesophagogastroduodenoscopy|Upper GI endoscopy|egds|Fiberoptic esophagogastroduodenoscopy (procedure)|Upper gastrointestinal tract examination | Esophagogastroduodenoscopy |
C0028978 | A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. | omeprazole product|Omeprazole-containing product|Product containing omeprazole (medicinal product)|Omeprazol|Omeprazolum|OMEPRAZOLE|1H-Benzimidazole, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-|Omeprazole (substance)|Omeprazole|5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole|omeprazole|OMEP | omeprazole |
C0358591 | Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. | Product containing hydrogen/potassium adenosine triphosphatase enzyme system inhibitor (product)|Substance with H+/K+-exchanging ATPase inhibitor mechanism of action|PPI|Proton pump inhibitor-containing product|inhibitor proton pump|H+/K+-exchanging ATPase inhibitor|Proton pump inhibitor|Substance with hydrogen/potassium adenosine triphosphatase enzyme system inhibitor mechanism of action (substance)|inhibitors proton pump|proton pump inhibitors|Proton Pump Inhibitors|H+/K+-exchanging ATPase inhibitor-containing product|Proton Pump Inhibitor|Inhibitors, Proton Pump|proton pump inhibitor|Proton pump inhibitors | Proton Pump Inhibitors |
C0008370 | Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). | Cholestasis (finding)|Occlusion of bile duct, NOS|Stases, Biliary|bile ducts obstruction|of bile duct obstruction|Bile duct obstruction|biles ducts obstructions|BILIARY STASIS|Stasis, Biliary|Biliary Stasis|bile obstruction|Obstructions, Bile Duct|Biliary stasis|cholestasis|Duct Obstruction, Bile|biles ducts obstruction|Occlusion of bile duct|Duct Obstructions, Bile|bile stasis|Bile stasis, NOS|bile ducts obstructions|Slowed or blocked flow of bile from liver|Biliary Stases|Bile duct occlusion|Bile stasis|Cholestasis, NOS|Obstruction of bile duct (disorder)|Obstruction of bile duct, NOS|Bile Duct Obstruction|Obstruction, Bile Duct|Obstruction of bile duct|Cholestasis|cholestases|Occlusion of bile duct (disorder)|Cholestases|bile duct obstruction|obstruction of bile duct|bile occlusion|obstruction bile duct|biliary stasis|Bile Duct Obstructions | Cholestasis |
C0014868 | INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA. | Esophagitis, unspecified|Esophagitis NOS|Esophagitides|Inflammation of esophagus|Esophagitis (disorder)|Esophagitis|oesophagitis|esophagitis|Inflammation of the esophagus|Esophagitis, NOS|Oesophagitis|Oesophagitis, NOS|ESOPHAGITIS|esophagus inflammation|OESOPHAGITIS | Esophagitis |
C0070329 | null | ahpatinin C|Pepsin inhibitor S 735A|Pepstatin|Procidin S 735A|Pepstatin A|pepstatin A|PEPSTATIN|Ahpatinin C|N-Isovaleryl-L-valyl-L-valyl-3-hydroxy-6-methyl-gamma-aminoheptanoyl-L-alanyl-3-hydroxy-6-methyl-gamma-aminoheptanoic Acid | pepstatin |
C0209315 | null | 12-sulfodehydroabietic acid|Ecabetum|ECABET|Ecabet | ecabet |
C1160577 | The controlled release of acid by a cell or a tissue. [GOC:ai] | acid secretion | acid secretion |
C0017797 | A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells. | (S)-2,5-diamino-5-oxopentanoic acid|l-glutamine|glutamic acid 5-amide|L-GLUTAMINE|(2S)-2,5-diamino-5-oxopentanoic acid|Glutamine (substance)|Levoglutamide|Q. Levoglutamide|Glutamine-containing product|L-glutamic acid γ-amide|L-glutamine|glutamine|(2S)-2-amino-4-carbamoylbutanoic acid|L-Glutamin|Glutamic acid 5-amide|l glutamine|2-aminoglutaramic acid|Gln - Glutamine|L Glutamine|Glutamine|Glutamic acid amide|Product containing glutamine (medicinal product)|levoglutamide|L-Glutaminsäure-5-amid|L-Glutamine|GLUTAMINE,L-|GLUTAMINE|(S)-2-Aminopentane-dioic acid 5-amide|Q|Gln|Glutamina|L-(+)-glutamine|L-2-aminoglutaramic acid | glutamine |
C0030859 | A synthetic pentapeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid. | Pentagastrin-containing product|Product containing pentagastrin (medicinal product)|L-Phenylalaninamide, N-((1,1-dimethylethoxy)carbonyl)-beta-alanyl-L-tryptophyl-L-methionyl-L-alpha-aspartyl-|pentagastrin|PG - Pentagastrin|Pentagastrin preparation|Pentagastrin|PENTAGASTRIN|Pentapeptide, Gastrin|Pentagastrin (substance)|Gastrin Pentapeptide | pentagastrin |
C0526470 | null | HU210|HU-210 | HU 210 |
C0741614 | Surgical removal of part or all of the intestine. | bowel resection|bowel resections|resection bowel|bowels resection|Bowel Resection | Intestine Resection |
C0025219 | A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant. | N-[2-(5-methoxyindol-3-yl)ethyl]acetamide|Melatonin-containing product|MELATONIN|Melatonina|Melatonin (substance)|N-Acetyl-5-methoxytryptamine|Mélatonine|N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide|5-methoxy-N-acetyltryptamine|Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-|MLT|5-Methoxy-N-acetyltryptamine|Product containing melatonin (medicinal product)|melatonin|MIH|melanocyte-inhibiting factor|Melatonin | melatonin |
C0192601 | Surgical removal of part or all of the small intestine. | SMALL INTESTINE: EXCISIONS|Small Intestine: Excision|Resection of small intestine|Small Intestine: Excisions|resection of small intestine|Small Intestine Resection|Small Bowel Resection|small intestine resection|Excision small intestine|Small intestine excision (procedure)|small bowel resection|Small Bowel Excision|bowel resection small|Small bowel resection | Small intestine excision |
C0025219 | A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant. | N-[2-(5-methoxyindol-3-yl)ethyl]acetamide|Melatonin-containing product|MELATONIN|Melatonina|Melatonin (substance)|N-Acetyl-5-methoxytryptamine|Mélatonine|N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide|5-methoxy-N-acetyltryptamine|Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-|MLT|5-Methoxy-N-acetyltryptamine|Product containing melatonin (medicinal product)|melatonin|MIH|melanocyte-inhibiting factor|Melatonin | melatonin |
C0677646 | null | cells crypt|crypt cell | crypt cell |
C0036992 | A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT. | SBS - Short bowel syndrome|Short intestine syndrome|short-bowel syndrome|Short Bowel Syndromes|Syndrome, Short Bowel|short bowel syndrome|Post-resection short bowel syndrome|Postresectional malabsorption syndrome|Short Bowel Syndrome|syndrome intestine short|short gut syndrome|Short gut syndrome|Syndromes, Short Bowel|Bowel Syndromes, Short|Bowel Syndrome, Short|Short bowel syndrome (disorder)|Short-gut syndrome|Acquired short bowel syndrome|SHORT-BOWEL SYNDROME|MASSIVE BOWEL RESECTION SYNDROME|SGS - Short gut syndrome|Short bowel syndrome|short bowel syndromes|Acquired short bowel syndrome (disorder)|bowel short syndrome | Short Bowel Syndrome |
C1096244 | null | null | intestinal resection |
C0600072 | null | Feeding and dietary regime|Feeding and dietary regime (regime/therapy) | Feeding and dietary regimes |
C0019196 | INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally, and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. | HCV|HCV Infection|Viral hepatitis type C (disorder)|Unspecified viral hepatitis C|hepatitis nonA nonB|non b hepatitis|hepatitis c|hepatitis c viral|Viral hepatitis type C|HEPATITIS, NON-A, NON-B|Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted|hepatitis non-a non-b|Unspecified viral hepatitis C NOS|Hepatitis C Virus Infection|hepatitis C|Viral hepatitis, non-A, non-B|HEPATITIS C VIRUS|nonA nonB hepatitis|Parenterally-Transmitted Non-A, Non-B Hepatitis|NANBH|Non-A, non-B hepatitis|Viral hepatitis C|Hepatitis C|Non-A, Non-B Hepatitis|hepatitis viral c|Hepatitis C Infection|viral hepatitis c|PT-NANBH|hepatitis C infection|Parenterally Transmitted Non A, Non B Hepatitis|Type C viral hepatitis|Hepatitis, Non-A, non-B|hepatitis non A non B | Hepatitis C |
C0023896 | Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS. | alcoholic liver disease|ALD - Alcoholic liver disease|Alcoholic liver disease, NOS|alcoholic diseases liver|Alcoholic liver diseases|alcohol induced liver disorder|Alcoholic Liver Diseases|ALCOHOLIC LIVER DISEASE|Alcoholic Liver Disease|Liver Disease, Alcoholic|alcoholic liver disorder|alcoholics disease liver|Liver Diseases, Alcoholic|alcoholic liver diseases|Alcoholic liver disease|alcoholic disease liver | Alcoholic Liver Diseases |
C0439775 | null | Elevation|elevation procedure|Elevation (procedure)|elevation|Elevation, NOS | Elevation procedure |
C0282193 | An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. (From Churchill's Illustrated Medical Dictionary, 1989) | Iron overload|iron excess|overload iron|Iron excess|Iron Overload|excesses iron|iron overload disorder|Overload, Iron|Increased storage iron|iron overload|iron overloading|excess iron|Iron overload, NOS|Iron overload (disorder) | Iron Overload |
C0014867 | Abnormally dilated veins of the esophagus. | Oesophageal varices|Esophageal Varices|Varices, Esophageal|Varix, Esophageal|Enlarged vein in esophagus|esophagus varicose veins|VARICES ESOPHAGEAL|OV - Oesophageal varices|varices esophageal|Esophageal varix|Oesophageal varices, NOS|varix esophagus|oesophageal varices|OESOPHAGEAL VARICES|ESOPHAGEAL VARICES|ESOPHAGUS, VARIX|Esophageal Varix|Oesophageal varix|esophageal varices|OV - Esophageal varices|Esophageal varices (diagnosis)|Esophageal varices|esophageal varice|Esophageal varices (disorder)|ESOPHAGEAL VARIX|varicose veins esophagus|Esophageal varices, NOS|esophageal varix | Esophageal Varices |
C0267797 | Acute inflammation of the liver. | Acute Hepatitis|Acute liver inflammation|Acute hepatitis (disorder)|acute hepatitis|Acute hepatitis, NOS|Acute hepatitis|hepatitis acute | Acute hepatitis |
C0079487 | Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. | Helicobacter Infections|Helicobacter infections|Infections, Helicobacter|Helicobacter Infection|helicobacter infection|helicobacter infections|Infection, Helicobacter | Helicobacter Infections |
C0850666 | A bacterial infection of the stomach, caused by Helicobacter pylori. It is associated with the development of peptic ulcer and mucosa-associated lymphoid tissue lymphoma. | Helicobacter pylori infection|helicobacter infections pylori|H. Pylori Infections|Helicobacter Pylori Infection|helicobacter pylori infection|Helicobacter Pylori Infections|H. pylori Infection|h pylori infection|h infection pylori|H. Pylori Infection|Infection caused by Helicobacter pylori (disorder)|h infections pylori | Infection caused by Helicobacter pylori |
C0042458 | The venous trunk which receives blood from the lower extremities and from the pelvic and abdominal organs. | INFERIOR VENA CAVA|inferior vena cava|cava inferior vena|Inferior vena cava structure|Vena cava, Inferior|Caudal vena cava|Vena cava inferior|Inferior vena cava structure (body structure)|Inferior Vena Cavas|vena cava inferior|Posterior vena cava|Inferior vena cava|Inferior Vena Cava|Vena Cavas, Inferior|Vena Cava, Inferior | Inferior vena cava structure |
C0001733 | A deficiency or absence of FIBRINOGEN in the blood. | afibrinogenaemia|FACTOR I DEFICIENCY, COMPLETE|afibrinogenemia|Afibrinogenemias|Afibrinogenaemia|Afibrinogenemia (disorder)|AFIBRINOGENEMIA|Afibrinogenemia | Afibrinogenemia |
C0019154 | An obstruction in the veins of the liver caused by a blood clot (thrombosis). [HPO:probinson] | Hepatic vein thrombosis (disorder)|Thrombosis, Hepatic Vein|hepatic vein thrombosis|Vein Thromboses, Hepatic|chiari syndromes|Blood clot in liver vein|chiari syndrome|chiari's syndrome|Vein Thrombosis, Hepatic|Hepatic vein thrombosis|budd chiari syndrome|hepatic vein obstruction|Hepatic Vein Thromboses|HEPATIC VEIN OBSTRUCTION|Hepatic venous thrombosis|budd-chiari syndrome|Thromboses, Hepatic Vein|budd chiari's syndrome|Hepatic Vein Thrombosis | Hepatic Vein Thrombosis |
C0079225 | A long chain polymer of sulfated glucose with strong hydrophilic properties that binds to various membranes. Dextran sulfate has been shown to inhibit the binding of HIV-1 to CD4+ T lymphocytes by specific binding of virion-associated gp120. | dextran sulfate sodium|Sulfate Sodium, Dextran|Dextran Sulfate, Sodium|Sodium Dextran Sulfate|Sulfate, Sodium Dextran|Dextran Sulfate Sodium | Dextran Sulfate Sodium |
C0079225 | A long chain polymer of sulfated glucose with strong hydrophilic properties that binds to various membranes. Dextran sulfate has been shown to inhibit the binding of HIV-1 to CD4+ T lymphocytes by specific binding of virion-associated gp120. | dextran sulfate sodium|Sulfate Sodium, Dextran|Dextran Sulfate, Sodium|Sodium Dextran Sulfate|Sulfate, Sodium Dextran|Dextran Sulfate Sodium | Dextran Sulfate Sodium |
C1522057 | null | Duodenitis|Acute Enteritis of the Mouse Intestinal Tract | Acute Enteritis of the Mouse Intestinal Tract |
Subsets and Splits
No saved queries yet
Save your SQL queries to embed, download, and access them later. Queries will appear here once saved.